Pluri Inc.
Biotechnology firm with 3D cell-expansion tech for manufacturing cell-based products.
PLUR | TA
Overview
Corporate Details
- ISIN(s):
- US72942G2030
- LEI:
- Country:
- Israel
- Address:
- Park Building No. 5, 3508409 Haifa
- Website:
- https://pluri-biotech.com/
- Sector:
- Manufacturing
Description
Pluri Inc. is a biotechnology company specializing in proprietary 3D cell-expansion technology. The company develops and operates platforms for the scalable, consistent, and cost-effective manufacturing of cell-based products. Its technology is applied across multiple sectors, including regenerative medicine, cell therapy, food technology, and agriculture technology (AgTech). Pluri aims to create next-generation cell-based products to improve human wellbeing and establishes partnerships to leverage its platform. The company also provides Contract Development and Manufacturing Organization (CDMO) services.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-12-20 00:29 |
8K: Pluri Prices $8.2 million Private Placement Offerings
|
English | 36.1 KB | ||
| 2022-12-16 00:05 |
Pluri Prices $8.2 million Private Placement Offerings
|
English | 79.9 KB | ||
| 2022-12-16 00:05 |
Pluri Prices $8.2 million Private Placement Offerings
|
English | 36.1 KB | ||
| 2022-11-11 00:12 |
Form 10-Q -Sep 30, 2022 Financial Results
|
English | 292.6 KB | ||
| 2022-11-11 00:12 |
Form 10-Q -Sep 30, 2022 Financial Results
|
English | 36.3 KB | ||
| 2022-11-10 15:02 |
Pluri wins BioTech Breakthrough Cell Innovation of the Year Award
|
English | 90.0 KB | ||
| 2022-11-10 15:02 |
Pluri wins BioTech Breakthrough Cell Innovation of the Year Award
|
English | 36.1 KB | ||
| 2022-10-31 15:01 |
Pluri to Present and Participate in Upcoming Conferences
|
English | 87.5 KB | ||
| 2022-10-31 15:01 |
Pluri to Present and Participate in Upcoming Conferences
|
English | 36.1 KB | ||
| 2022-10-14 01:41 |
FORM 8-K - Notice of Delisting or Failure to Satisfy a Continued Listing Rule o…
|
English | 112.7 KB | ||
| 2022-10-14 01:41 |
FORM 8-K - Notice of Delisting or Failure to Satisfy a Continued Listing Rule o…
|
English | 36.1 KB | ||
| 2022-09-29 18:43 |
FORM 8-K-Pluri CEO Issues Letter to Shareholders Announcing New Tech Collaborat…
|
English | 178.5 KB | ||
| 2022-09-29 18:43 |
FORM 8-K-Pluri CEO Issues Letter to Shareholders Announcing New Tech Collaborat…
|
English | 36.1 KB | ||
| 2022-09-29 16:03 |
Pluri CEO Issues Letter to Shareholders Announcing New Tech Collaboration, Cost…
|
English | 115.0 KB | ||
| 2022-09-29 16:03 |
Pluri CEO Issues Letter to Shareholders Announcing New Tech Collaboration, Cost…
|
English | 36.0 KB |
Automate Your Workflow. Get a real-time feed of all Pluri Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pluri Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pluri Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
